Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and pharmacogenetic heterogeneity in opioid treatment for cancer pain
NL-OMON33024Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2010
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer pain, sponsored by Erasmus MC. Primary endpoints: Pain intensity, Opioid side effects and 1 more. Started Jan 2010; status: active, not recruiting.
02
Conditions
cancer pain
Beyond the preview
Go deeper on NL-OMON33024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33024.